Tom van der Wel

1.0k total citations
15 papers, 329 citations indexed

About

Tom van der Wel is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Tom van der Wel has authored 15 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 9 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Tom van der Wel's work include Cannabis and Cannabinoid Research (12 papers), Pancreatic function and diabetes (9 papers) and Diet, Metabolism, and Disease (4 papers). Tom van der Wel is often cited by papers focused on Cannabis and Cannabinoid Research (12 papers), Pancreatic function and diabetes (9 papers) and Diet, Metabolism, and Disease (4 papers). Tom van der Wel collaborates with scholars based in Netherlands, United States and Austria. Tom van der Wel's co-authors include Mario van der Stelt, Herman S. Overkleeft, Hans den Dulk, Hui Deng, Marc P. Baggelaar, Benjamin F. Cravatt, Adrianus M. C. H. van den Nieuwendijk, Daisuke Ogasawara, Marjolein Soethoudt and Juan Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Tom van der Wel

13 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom van der Wel Netherlands	9	208	112	83	82	45	15	329
Niina Aaltonen Finland	11	184 0.9×	145 1.3×	71 0.9×	53 0.6×	25 0.6×	19	352
Albert J. Uveges United States	9	187 0.9×	401 3.6×	198 2.4×	53 0.6×	46 1.0×	11	658
Amanda J. Wheal United Kingdom	10	154 0.7×	229 2.0×	108 1.3×	21 0.3×	21 0.5×	10	429
A Finazzi-Agrò Italy	8	252 1.2×	120 1.1×	80 1.0×	57 0.7×	8 0.2×	18	437
Debora Zian Spain	7	154 0.7×	76 0.7×	56 0.7×	53 0.6×	213 4.7×	7	406
Magdalena Grzemska United States	5	225 1.1×	306 2.7×	168 2.0×	68 0.8×	11 0.2×	7	489
Asha Subramanian India	6	182 0.9×	50 0.4×	114 1.4×	28 0.3×	11 0.2×	7	355
Gillian Goodwin United Kingdom	3	224 1.1×	218 1.9×	226 2.7×	35 0.4×	23 0.5×	4	390
Derek Lowe United States	11	43 0.2×	166 1.5×	99 1.2×	29 0.4×	50 1.1×	18	382
Chiara Zanato United Kingdom	9	179 0.9×	120 1.1×	132 1.6×	13 0.2×	90 2.0×	23	350

Countries citing papers authored by Tom van der Wel

Since Specialization

Citations

This map shows the geographic impact of Tom van der Wel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom van der Wel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom van der Wel more than expected).

Fields of papers citing papers by Tom van der Wel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom van der Wel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom van der Wel. The network helps show where Tom van der Wel may publish in the future.

Co-authorship network of co-authors of Tom van der Wel

This figure shows the co-authorship network connecting the top 25 collaborators of Tom van der Wel. A scholar is included among the top collaborators of Tom van der Wel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom van der Wel. Tom van der Wel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Straub, Verena M., Tom van der Wel, Laura H. Heitman, et al.. (2025). The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles. Proceedings of the National Academy of Sciences. 122(8). e2421717122–e2421717122. 6 indexed citations

Wel, Tom van der, et al.. (2024). Previously Published Phosphatase Probes have Limited Utility Due to their Unspecific Reactivity. ChemBioChem. 25(22). e202400333–e202400333.

Jiang, Ming, Florian Mohr, Richard J. B. H. N. van den Berg, et al.. (2024). Structure–Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors. Journal of Medicinal Chemistry. 67(14). 12331–12348.

Wel, Tom van der, Birgit Hirschmugl, Juergen Gindlhuber, et al.. (2023). Inhibition of diacylglycerol lipase β modulates lipid and endocannabinoid levels in the ex vivo human placenta. Frontiers in Endocrinology. 14. 1092024–1092024. 3 indexed citations

Fazio, Domenico, Bogdan I. Florea, Tom van der Wel, et al.. (2022). Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437. ACS Chemical Biology. 17(5). 1174–1183. 8 indexed citations

Kwekkeboom, Joanneke C., Marieke Heijink, Tom van der Wel, et al.. (2022). Comparative Photoaffinity Profiling of Omega-3 Signaling Lipid Probes Reveals Prostaglandin Reductase 1 as a Metabolic Hub in Human Macrophages. Journal of the American Chemical Society. 144(41). 18938–18947. 16 indexed citations

Wel, Tom van der, Riet Hilhorst, Hans den Dulk, et al.. (2020). Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis. Nature Communications. 11(1). 3216–3216. 9 indexed citations

Zhou, Juan, Elliot D. Mock, Xinyu Di, et al.. (2020). Structure–Activity Relationship Studies of α-Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family. Journal of Medicinal Chemistry. 63(17). 9340–9359. 11 indexed citations

Esbroeck, Annelot C. M. van, Vasudev Kantae, Xinyu Di, et al.. (2019). Identification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells. Frontiers in Molecular Neuroscience. 12. 286–286. 20 indexed citations

10.

Deng, Hui, Tom van der Wel, Richard J. B. H. N. van den Berg, et al.. (2017). Chiral disubstituted piperidinyl ureas: a class of dual diacylglycerol lipase-α and ABHD6 inhibitors. MedChemComm. 8(5). 982–988. 8 indexed citations

11.

Deng, Hui, Sander Kooijman, Adrianus M. C. H. van den Nieuwendijk, et al.. (2016). Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding. Journal of Medicinal Chemistry. 60(1). 428–440. 31 indexed citations

12.

Ogasawara, Daisuke, Hui Deng, Andreu Viader, et al.. (2015). Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition. Proceedings of the National Academy of Sciences. 113(1). 26–33. 118 indexed citations

13.

Wel, Tom van der, Marc P. Baggelaar, Hui Deng, et al.. (2015). A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α. Journal of Lipid Research. 56(4). 927–935. 23 indexed citations

14.

Baggelaar, Marc P., Pascal Chameau, Vasudev Kantae, et al.. (2015). Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in Neurons. Journal of the American Chemical Society. 137(27). 8851–8857. 47 indexed citations

15.

Deng, Hui, Marc P. Baggelaar, Marco Allarà, et al.. (2014). Discovery of Glycine Sulfonamides as Dual Inhibitors ofsn-1-Diacylglycerol Lipase α and α/β-Hydrolase Domain 6. Journal of Medicinal Chemistry. 57(15). 6610–6622. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact